HOUSTON, October 23, 2023 Kiromic BioPharma, Inc. (OTC PINK: KRBP) ("Kiromic" or the "Company"), a clinical-stage, fully-integrated biotherapeutics company using its proprietary DIAMOND® artificial intelligence and data mining platform to develop cell therapies with a focus on immuno-oncology, announces the execution of a clinical trial agreement with Beverly Hills Cancer Center (BHCC) to conduct its Deltacel-01 Phase 1 Study. Pursuant to the agreement, BHCC, one of Southern California’s esteem
Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14 tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Kiromic BioPharma Common Stock to Begin Trading on the OTC Pink Sheets on September 14 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Free Report) was the recipient of a large decline in short interest during the month of August. As of August 15th, there was short interest totalling 49,800 shares, a decline of 20.2% from the July 31st total of 62,400 shares. Approximately 4.4% of the shares of the stock are […]